Patent details

EP3200879 Title: COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME III

Basic Information

Publication number:
EP3200879
PCT Application Number:
EP2015072386
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157719303
PCT Publication Number:
WO2016050749
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME III
French Title of Invention:
TRAITEMENT COMBINÉ DE LA LEUCÉMIE AIGUË MYÉLOÏDE ET DU SYNDROME MYÉLODYSPLASIQUE III
German Title of Invention:
KOMBINATIONSBEHANDLUNG VON AKUTER MYELOISCHER LEUKÄMIE UND MYELODYSPLASTISCHEM SYNDROM III
SPC Number:

Dates

Filing date:
29/09/2015
Grant date:
15/08/2018
EP Publication Date:
09/08/2017
PCT Publication Date:
07/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/08/2018
EP B1 Publication Date:
15/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/09/2018
Expiration date:
29/09/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/08/2018
 
 

Name:
Boehringer Ingelheim International GmbH & Co. KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
RUDOLPH, Dorothea
Address:
Germany (DE)

2

Name:
TAUBE, Tillmann
Address:
Germany (DE)

Priority

Priority Number:
14187331
Priority Date:
01/10/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/519; A61K 31/5377; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
201833
Publication date:
15/08/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/01/2019 Outgoing Correspondence 1